New Data Finds AstraZeneca Booster Generates Higher Antibodies Against Omicron as Booster Dose

Preliminary Data Shows Vaxzevria Given As Third Dose Ups Antibody Response to Omicron: AstraZeneca

Biopharmaceutical multinational AstraZeneca on Thursday said the preliminary analysis of ongoing safety and immunogenicity trial has indicated that Vaxzevria, when given as a third dose booster, increased antibody response to the Omicron variant. The study also noted that the booster dosage of the company’s Covid-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, […]

Continue Reading